Derivative of adult T cell leukemia virus antigen peptide
US4795805A · kind A · utility
14Cited by
5References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 1987 |
| Grant date | Jan 3, 1989 |
| Priority date | — |
| Expiry date | Oct 2, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Recombinant plasmids are constructed by inserting a DNA fragment coding for a fused protein of an adult T cell leukemia virus antigen peptide and an enzyme into a vector DNA. Microorganisms are transformed with the recombinant plasmid and thereafter cultured to express the fused protein. The fused protein is useful for the detection and diagnosis of adult T cell leukemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.